Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update

• Published in: Gynecologic oncology Vol. 173; pp. 58 - 67
• Main Authors: Nelson, G., Fotopoulou, C., Taylor, J., Glaser, G., Bakkum-Gamez, J., Meyer, L.A., Stone, R., Mena, G., Elias, K.M., Altman, A.D., Bisch, S.P., Ramirez, P.T., Dowdy, S.C.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2023
• Subjects: Enhanced Recovery After Surgery; ERAS; Female; Genital Neoplasms, Female - surgery; Gynecologic oncology surgery; Gynecologic Surgical Procedures; Hematology, Oncology, and Palliative Medicine; Humans; Obstetrics and Gynecology; Perioperative Care; Prospective Studies; Surgical quality; Gynecologic oncology surgery; Enhanced recovery after surgery; Perioperative care; ERAS; Surgical quality
• ISSN: 0090-8258; 1095-6859; 1095-6859
• DOI: 10.1016/j.ygyno.2023.04.009

Despite evidence supporting its use, many Enhanced Recovery After Surgery (ERAS) recommendations remain poorly adhered to and barriers to ERAS implementation persist. In this second updated ERAS® Society guideline, a consensus for optimal perioperative care in gynecologic oncology surgery is presented, with a specific emphasis on implementation challenges. Based on the gaps identified by clinician stakeholder groups, nine implementation challenge topics were prioritized for review. A database search of publications using Embase and PubMed was performed (2018–2023). Studies on each topic were selected with emphasis on meta-analyses, randomized controlled trials, and large prospective cohort studies. These studies were then reviewed and graded by an international panel according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) system. All recommendations on ERAS implementation challenge topics are based on best available evidence. The level of evidence for each item is presented accordingly. The updated evidence base and recommendations for stakeholder derived ERAS implementation challenges in gynecologic oncology are presented by the ERAS® Society in this consensus review. •Despite best efforts, many of the ERAS recommendations remain poorly adhered to and barriers to ERAS implementation persist.•This guideline update summarizes evidence investigating ERAS implementation challenges highlighted by stakeholder groups.•Overcoming implementation barriers will increase ERAS uptake and improve clinical outcomes for patients.